Filters

Alan K Burnett, Robert K Hills, Donald W Milligan, Anthony H Goldstone, Archibald G Prentice, Mary-Frances McMullin, Andrew Duncombe, Brenda Gibson, Keith Wheatley

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(4):586-95

Full Text

Abstract

Toxicity and efficacy of intensive chemotherapy for children with acute lymphoblastic leukemia (ALL) after first bone marrow or extramedullary relapse.

Blythe Thomson, Julie R Park, Judy Felgenhauer, Soheil Meshinchi, John Holcenberg, J Russell Geyer, Vassilios Avramis, James G Douglas, Michael R Loken, Douglas S Hawkins

Pediatric blood & cancer 2004;43(5):571-9

Full Text

Abstract

The impact on outcome of the addition of all-trans retinoic acid to intensive chemotherapy in younger patients with nonacute promyelocytic acute myeloid leukemia: overall results and results in genotypic subgroups defined by mutations in NPM1, FLT3, and CEBPA.

Alan K Burnett, Robert K Hills, Claire Green, Sarah Jenkinson, Kenneth Koo, Yashma Patel, Carol Guy, Amanda Gilkes, Donald W Milligan, Anthony H Goldstone, Archibald G Prentice, Keith Wheatley, David C Linch, Rosemary E Gale

Blood 2010;115(5):948-56

Free Full Text

Abstract

Outcome of elderly patients with acute promyelocytic leukemia: results of the German Acute Myeloid Leukemia Cooperative Group.

Eva Lengfelder, Benjamin Hanfstein, Claudia Haferlach, Jan Braess, Utz Krug, Karsten Spiekermann, Torsten Haferlach, Karl-Anton Kreuzer, Hubert Serve, Heinz A Horst, Susanne Schnittger, Carlo Aul, Beate Schultheis, Philipp Erben, Stephanie Schneider, Carsten Müller-Tidow, Bernhard Wörmann, Wolfgang E Berdel, Cristina Sauerland, Achim Heinecke, Rüdiger Hehlmann, Wolf-Karsten Hofmann, Wolfgang Hiddemann, Thomas Büchner

Annals of hematology 2013;92(1):41-52

Free Full Text

Abstract

Have all-trans retinoic acid and arsenic trioxide replaced all-trans retinoic acid and anthracyclines in APL as standard of care.

Harry J Iland, Andrew Wei, John F Seymour

Best practice & research. Clinical haematology 2015;27(1):39-52

Full Text

Abstract

Results: 1 – 14 / 14

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Thioguanine""[mesh_terms]

6-thioguanine in the treatment of psoriasis: a case report and literature review.

Thiopurine therapies: problems, complexities, and progress with monitoring thioguanine nucleotides.

Cytosine derivatized bis(2,2'-bithienyl)methane molecularly imprinted polymer for selective recognition of 6-thioguanine, an antitumor drug.

BRCA1-deficient breast cancer cell lines are resistant to MEK inhibitors and show distinct sensitivities to 6-thioguanine.

Reduction-sensitive tioguanine prodrug micelles.

Thiopurine Therapy in Patients With Inflammatory Bowel Disease: A Focus on Metabolism and Pharmacogenetics.

6-Thioguanine Nucleotide Levels Are Associated With Mucosal Healing in Patients With Crohn's Disease.

Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease.

The clinical impact of thiopurine methyltransferase polymorphisms on thiopurine treatment.

Attempts to optimize induction and consolidation treatment in acute myeloid leukemia: results of the MRC AML12 trial.

Toxicity and efficacy of intensive chemotherapy for children with acute lymphoblastic leukemia (ALL) after first bone marrow or extramedullary relapse.

The impact on outcome of the addition of all-trans retinoic acid to intensive chemotherapy in younger patients with nonacute promyelocytic acute myeloid leukemia: overall results and results in genotypic subgroups defined by mutations in NPM1, FLT3, and CEBPA.

Outcome of elderly patients with acute promyelocytic leukemia: results of the German Acute Myeloid Leukemia Cooperative Group.

Have all-trans retinoic acid and arsenic trioxide replaced all-trans retinoic acid and anthracyclines in APL as standard of care.

Results for
""Thioguanine""[mesh_terms]